AIMOVIG vs REGROTON

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. AIMOVIG and REGROTON are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	REGROTON
Rating	72/100	70/100
Pharmacy pays	—	~$2.67 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	CHLORTHALIDONE AND RESERPINE
Manufacturer	Amgen Inc	Sanofi Aventis US
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

aimovig regroton

Rating

72/100

70/100

Pharmacy pays

—

~$2.67 /30

Type

Active ingredient

ERENUMAB-AOOE

CHLORTHALIDONE AND RESERPINE

Manufacturer

Amgen Inc

Sanofi Aventis US

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Half-life

—

about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

Frequently asked questions

Which is better-rated, Aimovig or Regroton?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Regroton. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Regroton?

Aimovig contains Erenumab-Aooe, while Regroton contains Chlorthalidone and Reserpine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.